Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Cisarua Mountain Dairy / Equity Capital Markets

<ul>
<li><strong>Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. </strong></li>
<li>Hong Kong IPO pipeline looks strong with Weilong Delicious Global, CANbridge Pharmaceuticals,  Asymchem Laboratories, and China Tourism Group either close to approval or seeking approval with HKEX soon.</li>
<li>Indonesia ECM is looking busier than ever this year with the launch of Cisarua Mountain Dairy (Cimory) and PT Avia Avian IPO bookbuilds this week.</li>
</ul>


Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. 
Hong Kong IPO pipeline looks strong with Weilong Delicious Global, CANbridge Pharmaceuticals,  Asymchem Laboratories, and China Tourism Group either close to approval or seeking approval with HKEX soon.
Indonesia ECM is looking busier than ever this year with the launch of Cisarua Mountain Dairy (Cimory) and PT Avia Avian IPO bookbuilds this week.


ECM Weekly (14th November 2021) - Cimory, Infervision, Daiwa House REIT, Weilong Delicious

HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

CANbridge Pharmaceuticals / Equity Capital Markets

<p>Since June this year, there have been more and more topics about rare diseases in China. On June 30, Shaanxi Provincial Medical Insurance Bureau included 7 drugs for rare diseases such as Gaucher disease, Fabry disease and others into Shaanxi Provincial medical insurance coverage. On July 5, Jiangsu Province also added five rare diseases including Pompe disease, Spinal Muscular Atrophy and others to its medical insurance coverage. As rare diseases gradually attract government’s attention, related companies would also come into people’s vision. On June 30, <a href="https://www.smartkarma.com/entities/canbridge-pharmaceuticals-inc" target="_blank" data-smartkarma-citation="entities:33783:1" rel="noopener">CANbridge Pharmaceuticals (CAN HK)</a>, a leading China-based, global rare disease-focused biopharmaceutical company, submitted its prospectus to the HKEX. This insight mainly analyzed the industry characteristics, the commercialized products, the pipeline, and the concerns of the Company.</p>

Since June this year, there have been more and more topics about rare diseases in China. On June 30, Shaanxi Provincial Medical Insurance Bureau included 7 drugs for rare diseases such as Gaucher disease, Fabry disease and others into Shaanxi Provincial medical insurance coverage. On July 5, Jiangsu Province also added five rare diseases including Pompe disease, Spinal Muscular Atrophy and others to its medical insurance coverage. As rare diseases gradually attract government’s attention, related companies would also come into people’s vision. On June 30, CANbridge Pharmaceuticals (CAN HK), a leading China-based, global rare disease-focused biopharmaceutical company, submitted its prospectus to the HKEX. This insight mainly analyzed the industry characteristics, the commercialized products, the pipeline, and the concerns of the Company.

Pre-IPO CANbridge Pharmaceuticals - Insights on Products, Pipeline and the Concerns

China

Concord Medical Services Holdings Ltd. manages medical centers. The Company owns and operates a network of radiotherapy and diagnostic imaging centers throughout China.

New Ray Medicine International Holdings Limited is a pharmaceutical distributor based in China.

China NT Pharma Group Company Ltd. manufactures generic pharmaceuticals, and offers logistics and promotions and sales service to other drug manufacturers. The Company offers customs clearance, warehousing, delivery, invoicing, receivables collection and other services; and promotion and sales services primarily for anti-infective and central nervous system medications.

Wanjia Group Holdings Ltd is a wholesaler and distributor and retail chain operator of pharmaceutical and healthcare products in Fujian Province in the PRC.

Kingworld Medicines Group Ltd. distributes branded imported pharmaceutical and healthcare products in the Peoples Republic of China. The Company distributes pharmaceuticals that include cough and phlegm relieving, gastrointestinal, vitamin, orthopedics, cardiovascular, influenza and others.

New Century Healthcare Holding Co. Limited operates hospitals. The Company manages pediatrics, obstetrics, and gynecology specialty hospitals throughout China.

Guangdong Kanghua Healthcare is a Guangdong based hospital operator.

IVD Medical Holding Limited operates as a holding company. The Company, through its subsidiaries, focuses on distribution of IVD products includes analysers, reagents, and other consumables. IVD Medical Holding serves customers in Hong Kong.

Rici Healthcare Holdings Limited operates private integrate health care hospitals. The Company provides high-end medicare, specialized hospital, physical examination, medical products supply, and other related services throughout China.

Zhejiang Zhenyuan Co., Ltd. wholesales and retails traditional Chinese medicines, Chinese medicine materials, chemical preparations, and healthcare products.  Through its subsidiaries, the Company also manufactures pharmaceuticals.

Wattana Karnpaet Public Company Limited operates North-Eastern Wattana Hospital. Located in Udorn-Thani, a north-eastern province of Thailand, the Hospital has approximately 100 beds for inpatients and 10 clinics which can serve up to 300 outpatients per day. The Hospital has 13 full-time physicians and 53 consulting physicians.

MRT Inc. provides staffing agency for full-time medical doctors and locum doctors through interest service. The Company also introduces medical staffing for registered nurses and clinical laboratory technicians.

CEDAR. Co., Ltd. is a nursing-service provider, and it mainly provides day care services for elderly in Fukuoka, Yamaguchi, and Chiba prefectures.  Its nursing-services include home care and helper services at clients' home. Cedar also operates nursing home for elderly and group home for ones with Alzheimer's disease.

Care Service Co. Ltd. provides nursing care services to the handicapped and elderly in Tokyo.  The Company's services include day-care, 24 hour home-visit care, home-stay care, and bathing services.  Care Service also conducts as a funeral director who assists the family with funeral arrangements, bathes and embalms the deceased body, and prepares the body by cosmeticizing and dressing.

Fortis Malar Hospitals Limited operates centers for trauma care in India. The hospitals perform orthopedic and trauma surgeries, cardiac care, renal transplants, neurosurgery, oto-laryngocoloy, limb reconstruction surgery and maxillofacial orthodontology.

Ceylon Hospitals PLC is a healthcare institution that provides clinical and nursing services to the people of Sri Lanka. The Hospitals offer facilities for pediatric cardiac surgical operations; a heart station; a catheterization laboratory, a digital cath laboratory and a cardiac operating theatre.

Nawaloka Hospitals PLC owns and operates the Nawaloka Hospital. The hospital offers a wide range of health care services.

Hang Chi Holdings Limited operates as a holding company. The Company, through its subsidiaries, provides medical care, rehabilitation, recreational activities arrangement, and other services. Hang Chi Holdings serves elders having lack of self-care abilities. Hang Chi Holdings offers its services in Hong Kong.

internet infinity INC. of Japan provides health care solutions with its health care platforms in senior markets. The Company provides home care services.

Established in May 2001, Cordlife Group Limited ("Cordlife", together with its subsidiaries, the "Group") is a leading company dedicated to safeguarding the well-being of mother and child. The Group is listed on the Mainboard of the Singapore Exchange since 2012 and is a pioneer in private cord blood banking in Asia.

Cordlife owns the largest network of cord blood banks in Asia with full stem cell banking facilities in six key markets, namely Singapore, Hong Kong, Indonesia, India, Malaysia and the Philippines. In Singapore, Hong Kong, the Philippines and Indonesia, Cordlife operates the largest private cord blood banks and it is amongst the top three market leaders in India and Malaysia. In January 2018, Cordlife became the market leader in Hong Kong with the acquisition of the largest private cord blood bank, Healthbaby Biotech (Hong Kong) Co., Limited. Through its majority-owned subsidiary in Malaysia, Stemlife Berhad, Cordlife holds an indirect stake in Thailand's largest private cord blood bank, Thai Stemlife. Cordlife has also established its presence in Myanmar, Vietnam, Macau, Brunei and Bangladesh.

Beyond cord blood, cord lining and cord tissue banking, Cordlife offers a comprehensive suite of diagnostics services for the family including non-invasive prenatal testing, paediatric vision screening, newborn metabolic screening and family genetic screening services.  Quality and customer focus are amongst some of the cornerstones of Cordlife.

CANbridge Pharmaceuticals operates as a global biopharmaceutical company. The Company focuses on developing and commercialising therapeutics for treatment of orphan diseases and rare cancers. CANbridge Pharmaceuticals serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

CANbridge Pharmaceuticals (1228 HK)

ECM Weekly (14th November 2021) - Cimory, Infervision, Daiwa House REIT, Weilong Delicious

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Sumeet Singh

Pre-IPO CANbridge Pharmaceuticals - Insights on Products, Pipeline and the Concerns

This article mainly analyzed CANbridge Pharmaceuticals in terms of its commercialized products, the pipeline, and the concerns, and the outlook of...

Xinyao (Criss) Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)